ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
nikki
|
230 |
104K |
11 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
230
|
104K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
7 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
6 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
6 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
5 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
4 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
nikki
|
50 |
15K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
50
|
15K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
7 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
nikki
|
8.9K |
3.3M |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
nikki
|
553 |
176K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
553
|
176K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: S&P DJI Announces September 2023 Quarterly Rebalance
|
|
nikki
|
49 |
23K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
49
|
23K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Almost Katelin's Turn :)
|
|
nikki
|
24 |
13K |
7 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
24
|
13K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
nikki
|
1.2K |
608K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
1.2K
|
608K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
nikki
|
1.2K |
608K |
14 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
1.2K
|
608K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Thank you all
|
|
nikki
|
105 |
55K |
6 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
105
|
55K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Trof sales
|
|
nikki
|
10 |
4.0K |
6 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
10
|
4.0K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Petra Capital 12% PT upgrade to $16.26
|
|
nikki
|
23 |
9.1K |
3 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
23
|
9.1K
|
3
|
|
ASX - By Stock
|
NEU |
Petra Capital 12% PT upgrade to $16.26
|
|
nikki
|
23 |
9.1K |
30 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
23
|
9.1K
|
30
|
|
ASX - By Stock
|
NEU |
Petra Capital 11% Upgrade
|
|
nikki
|
1 |
994 |
18 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
1
|
994
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: S&P DJI Announces September 2022 Quarterly Rebalance
|
|
nikki
|
4 |
4.2K |
2 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
4
|
4.2K
|
2
|
|
ASX - By Stock
|
NEU |
Petra capital upgrades PT on NEU
|
|
nikki
|
10 |
6.7K |
41 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
10
|
6.7K
|
41
|
|
ASX - By Stock
|
NEU |
New analyst coverage on NEU
|
|
nikki
|
8 |
5.9K |
23 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
8
|
5.9K
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nikki
|
10K |
3.0M |
0 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nikki
|
10K |
3.0M |
8 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
SNT |
Bell Potter upgrades to Buy, new target 14 cents
|
|
nikki
|
12 |
6.9K |
11 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
12
|
6.9K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
nikki
|
572 |
252K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
252K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Updated Broker Report: Bel Potter
|
|
nikki
|
165 |
79K |
3 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
165
|
79K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Bell Potter Initiates on IMM with Buy (spec)
|
|
nikki
|
2 |
2.1K |
6 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
2
|
2.1K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
$5 (USD) BUY RATING - Alliance Global Partners
|
|
nikki
|
6 |
3.8K |
0 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
6
|
3.8K
|
0
|
|
ASX - By Stock
|
IMM |
Bell Potter Initiates on IMM with Buy (spec)
|
|
nikki
|
2 |
2.1K |
36 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
2
|
2.1K
|
36
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma awarded $1M MRFF funding for COVID-19 spray
|
|
nikki
|
45 |
13K |
4 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
45
|
13K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma's DEP® remdesivir versus Gilead's Veklury (Remdesivir)
|
|
nikki
|
14 |
6.3K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
14
|
6.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Bell Potter raises target to $2.20
|
|
nikki
|
13 |
5.8K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
13
|
5.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
nikki
|
53 |
25K |
5 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
53
|
25K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - Most exciting 6 months
|
|
nikki
|
729 |
373K |
3 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
729
|
373K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
BP update (Tanu) .. GLTAH
|
|
nikki
|
56 |
31K |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
56
|
31K
|
2
|
|
ASX - By Stock
|
MVP |
Re:
Yet another favorable report
|
|
nikki
|
46 |
23K |
3 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
46
|
23K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chairman's Address and CEO Presentation
|
|
nikki
|
16 |
9.0K |
5 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
16
|
9.0K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chairman's Address and CEO Presentation
|
|
nikki
|
16 |
9.0K |
2 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
16
|
9.0K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
nikki
|
124 |
51K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
124
|
51K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
nikki
|
134 |
55K |
0 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
134
|
55K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
encouraging progress !
|
|
nikki
|
58 |
19K |
12 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
58
|
19K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
ACADIA TALKS TROFINETIDE
|
|
nikki
|
84 |
35K |
1 |
26/05/20 |
26/05/20 |
ASX - By Stock
|
84
|
35K
|
1
|
|